The Age-Specific Quantitative Effects of Metabolic Risk Factors on Cardiovascular Diseases and Diabetes: A Pooled Analysis
Open accessThe DOI matches its Crossref record; 66 of the 67 references it cites were found in a registry or an index.
Abstract
BACKGROUND: The effects of systolic blood pressure (SBP), serum total cholesterol (TC), fasting plasma glucose (FPG), and body mass index (BMI) on the risk of cardiovascular diseases (CVD) have been established in epidemiological studies, but consistent estimates of effect sizes by age and sex are not available. METHODS: We reviewed large cohort pooling projects, evaluating effects of baseline or usual exposure to metabolic risks on ischemic heart disease (IHD), hypertensive heart disease (HHD), stroke, diabetes, and, as relevant selected other CVDs, after adjusting for important confounders. We pooled all data to estimate relative risks (RRs) for each risk factor and examined effect modification by age or other factors, using random effects models. RESULTS: Across all risk factors, an average of 123 cohorts provided data on 1.4 million individuals and 52,000 CVD events. Each metabolic risk factor was robustly related to CVD. At the baseline age of 55-64 years, the RR for 10 mmHg higher SBP was largest for HHD (2.16; 95% CI 2.09-2.24), followed by effects on both stroke subtypes (1.66; 1.39-1.98 for hemorrhagic stroke and 1.63; 1.57-1.69 for ischemic stroke). In the same age group, RRs for 1 mmol/L higher TC were 1.44 (1.29-1.61) for IHD and 1.20 (1.15-1.25) for ischemic stroke. The RRs for 5 kg/m(2) higher BMI for ages 55-64 ranged from 2.32 (2.04-2.63) for diabetes, to 1.44 (1.40-1.48) for IHD. For 1 mmol/L higher FPG, RRs in this age group were 1.18 (1.08-1.29) for IHD and 1.14 (1.01-1.29) for total stroke. For all risk factors, proportional effects declined with age, were generally consistent by sex, and differed by region in only a few age groups for certain risk factor-disease pairs. CONCLUSION: Our results provide robust, comparable and precise estimates of the effects of major metabolic risk factors on CVD and diabetes by age group.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures




Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“and the risk of CVD increases continuously with rising fasting plasma glucose levels, even before reaching levels sufficient for a diabetes diagnosis [5].”
From Prevalence of cardiovascular disease in type 2 diabetes: a systematic literature review of scientific evidence from across the world in 2007–2017 (2018) · cites this paper as [5]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Lozano, R., Naghavi, M., Foreman, K., Lim, S., Shibuya, K., Aboyans, V., Abraham, J., Adair, T., Aggarwal, R., Ahn, S. Y., et al. (2012) · The Lancet · doi:10.1016/s0140-6736(12)61728-0 · Cited by 14,070
Self-citation(2002) · The Lancet · doi:10.1016/s0140-6736(02)11911-8 · Cited by 10,266
Self-citationTurner, R. C., Fox, C., Matthews, McElroy, H. H., Cull, C. A., Holman, R. R., Neil, P., Hadden, D. R., Wright, D., Manley, E., et al. (1998) · The Lancet · Cited by 8,419
Effects of Intensive Glucose Lowering in Type 2 Diabetes
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0802743 · Cited by 7,888
Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0802987 · Cited by 7,397 · cited 1×
“For BMI and FPG, confounding remains a concern as evidence from randomized trials of disease outcomes is either very limited for practical reasons (BMI) or provides mixed results (FPG) [49–52].”
BackgroundBariatric Surgery: A Systematic Review and Meta-analysis
Buchwald, H., Avidor, Y., Braunwald, E., Jensen, M. D., Pories, W., Fahrbach, K., & Schoelles, K. (2004) · JAMA · doi:10.1001/jama.292.14.1724 · Cited by 6,800 · cited 14×
“Metabolic risk factors We compared and pooled RRs for the effects of key metabolic risk factors: SBP, TC, FPG, and adiposity measured by BMI, from major global pooling projects.”
BackgroundInfluentialCholesterol Treatment Trialists' (CTT) Collaboration (2010) · The Lancet · doi:10.1016/s0140-6736(10)61350-5 · Cited by 6,550
The Emerging Risk Factors Collaboration (2010) · The Lancet · doi:10.1016/s0140-6736(10)60484-9 · Cited by 5,125
Research works printed but not linked: 2
- James WPT, Jackson-Leach R, Ni Mhurchu C, Kalamara E, Shayeghi M, <etal>et al</etal>.. (2004) Overweight and obesity (high body mass index). In: Ezzati M, Lopez AD, Rodgers A, Murray CJL, editors. Comparative quantification of health risks. Geneva: World Health Organization. pp. 497–596.
- Lawes CM, Vander Hoorn S, Law MR, Elliott P, MacMahon S, <etal>et al</etal>.. (2004) High Blood Pressure. In: Ezzati M, Lopez AD, Rodgers A, Murray CJL, editors. Comparative quantification of health risks. Geneva: World Health Organization. pp. 497–596.
Cited by
Items 201–300 of 772
Hyperuricemia as an independent risk factor for major cardiovascular events
Capuano, V., Marchese, F., Capuano, R., Torre, S., Iannone, A. G., Capuano, E., Lamaida, N., Sonderegger, M., & Capuano, E. (2016) · Journal of Cardiovascular Medicine · doi:10.2459/jcm.0000000000000347 · Cited by 34
Echouffo-Tcheugui, J. B., Niiranen, T. J., McCabe, E. L., Henglin, M., Jain, M., Vasan, R. S., Larson, M. G., & Cheng, S. (2020) · Diabetes Care · doi:10.2337/dc19-1758 · Cited by 28
Ichikawa, N., Ng, L. S., Makino, S., Goh, L. L., Lim, Y. J., Ferdinandus, F., Sasaki, H., Shibata, S., & Lee, K. C. L. (2022) · Metabolites · doi:10.3390/metabo12030198 · Cited by 35
“Furthermore, obesity is a risk factor for the development of several metabolic diseases [15,22] such as cardiovascular disease, type 2 diabetes [22], and cancer [23], making it a looming threat to public health.”
BackgroundHao, Q., Song, X., Yang, M. J., Dong, B., & Rockwood, K. J. (2016) · The journal of nutrition health & aging · doi:10.1007/s12603-016-0680-7 · Cited by 36
“The reasons for this are disputed (1, 2) - survivor bias is commonly cited (3).”
Long-term moderately elevated LDL-cholesterol and blood pressure and risk of coronary heart disease
Ueda, P., Gulayin, P., & Danaei, G. (2018) · PLoS ONE · doi:10.1371/journal.pone.0200017 · Cited by 34
Self-citationLiu, J., Zhong, Y., Luo, X., Ma, Y., Liu, J., & Wang, H. (2021) · Frontiers in Nutrition · doi:10.3389/fnut.2021.784681 · Cited by 34
Multidisciplinary Progress in Obesity Research
Lu, X., Jin, Y., Li, D., Zhang, J., Han, J., & Li, Y. (2022) · Genes · doi:10.3390/genes13101772 · Cited by 37
“Obesity is associated with many diseases, and is closely related to diseases, such as diabetes [6], cardiovascular disease [7], cancer [8], musculoskeletal disorders and psychological disorders [7].”
BackgroundBajgrowicz-Cieslak, M., Alqurashi, Y., Elshereif, M. I., Yetisen, A. K., Hassan, M. U., & Butt, H. (2017) · RSC Advances · doi:10.1039/c7ra11184c · Cited by 32
Tabaja, C., Younis, A., Santageli, P., Farwati, M., Braghieri, L., Nakagawa, H., Saliba, W. I., Madden, R. A., Bouscher, P., Kanj, M. H., et al. (2023) · Journal of Cardiovascular Electrophysiology · doi:10.1111/jce.15987 · Cited by 31
Colonna, K. J., Koutrakis, P., Kinney, P. L., Cooke, R. M., & Evans, J. S. (2022) · Environmental Science & Technology · doi:10.1021/acs.est.1c08343 · Cited by 35
Health Professional Advice and Adult Action to Reduce Sodium Intake
Jackson, S. L., King, S. M. C., Park, S.-Y., Fang, J., Odom, E., & Cogswell, M. E. (2015) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2015.04.034 · Cited by 36
“,(1) and elevated blood pressure is a major risk factor for CVD.(2) Sodium intake reduction is a key strategy for lowering blood pressure,(3) with an estimated 9.”
InfluentialShangguan, S., Mozaffarian, D., Sy, S., Lee, Y., Liu, J., Wilde, P., Sharkey, A. L., Dowling, E. A., Marklund, M., Abrahams‐Gessel, S., et al. (2021) · Circulation · doi:10.1161/circulationaha.121.053678 · Cited by 31
Self-citationExogenous butyrate regulates lipid metabolism through GPR41-ERK-AMPK pathway in rabbits
Zhang, B., Liu, H., Liu, M., Yue, Z., Liu, L., & Li, F. (2022) · Italian Journal of Animal Science · doi:10.1080/1828051x.2022.2049985 · Cited by 31
“Obesity has an adverse effect on almost all physiological functions of the body and poses a serious public health threat, increasing the risk of patients with many diseases (Singh et al. 2013).”
BackgroundMa, L.-J., Hou, X.-D., Qin, X., He, R.-J., Yu, H., Hu, Q., Guan, X., Jia, S.-N., Hou, J., Lei, T., et al. (2022) · Journal of Pharmaceutical Analysis · doi:10.1016/j.jpha.2022.04.002 · Cited by 32
Ning, X., Zhan, C., Yang, Y., Yang, L., Tu, J., Gu, H., Su, T., & Wang, J. (2014) · PLoS ONE · doi:10.1371/journal.pone.0116019 · Cited by 30
Own-price, cross-price, and expenditure elasticities on sugar-sweetened beverages in Guatemala
Chacón, V., Paraje, G. R., Barnoya, J., & Chaloupka, F. J. (2018) · PLoS ONE · doi:10.1371/journal.pone.0205931 · Cited by 32
Zheng, H., Xu, Z., Wang, Q., Ding, Z., Zhou, L., Xu, Y. J., Su, H., Li, X., Zhang, F., & Cheng, J. (2021) · Environmental Research · doi:10.1016/j.envres.2021.110804 · Cited by 32
Mizrak, I., Asserhøj, L. L., Lund, M. A. V., Kielstrup, L. R., Greisen, G. O., Clausen, T. D., Main, K. M., Jensen, R. B., Vejlstrup, N. G., Madsen, P. L., et al. (2021) · Human Reproduction · doi:10.1093/humrep/deab284 · Cited by 29
Nagy, E. L., Cseh, V., Barcs, I., & Ludwig, E. (2023) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph20021372 · Cited by 37
Chen-Ku, C. H., González-Gálvez, G., Vásquez, M., Fuente, G. V., Nakazone, M. A., Giordano, A. I. S., & Pereira, M. H. D. S. (2019) · Endocrine Practice · doi:10.4158/ep-2018-0473 · Cited by 33
Impact of glucose level on morbidity and mortality in elderly with diabetes and pre-diabetes
Twito, O., Frankel, M., & Nabriski, D. (2015) · World Journal of Diabetes · doi:10.4239/wjd.v6.i2.345 · Cited by 28
Jangjo-Borazjani, S., Dastgheib, M., Kiyamarsi, E., Jamshidi, R., Rahmati-Ahmadabad, S., Helalizadeh, M., Iraji, R., Cornish, S. M., Mohammadi-Darestani, S., Khojasteh, Z., et al. (2021) · Archives of Physiology and Biochemistry · doi:10.1080/13813455.2021.1886117 · Cited by 32
Deng, X., Zhang, N., Wang, Q., Huang, Y., Huang, Y., Lin, Y., Huang, M., Zheng, F., Xiao, M., & Ye, J. (2023) · European Journal of Nutrition · doi:10.1007/s00394-023-03089-w · Cited by 30
Khan, M. M. A., Karim, M., Islam, A. Z., Islam, M. R., Khan, H. T. A., & Khalilullah, M. I. (2019) · Journal of Biosocial Science · doi:10.1017/s0021932019000142 · Cited by 32
Melatonin relieves sepsis-induced myocardial injury via regulating JAK2/STAT3 signaling pathway
Zhen, G., Liang, W., Jia, H., & Zheng, X. (2021) · Minerva Medica · doi:10.23736/s0026-4806.20.06626-4 · Cited by 28
Iannone, A., Natale, P., Palmer, S. C., Nicolucci, A., Rendina, M., Giorgino, F., Laviola, L., Di Leo, A., & Strippoli, G. F. M. (2023) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.15138 · Cited by 27
Obesity-related knowledge and body mass index: a national survey in Portugal
Henriques, A., Azevedo, A., Lunet, N., Ferreira, P. M., do Carmo, I., & Silva, S. (2019) · Eating and Weight Disorders - Studies on Anorexia Bulimia and Obesity · doi:10.1007/s40519-019-00782-w · Cited by 29
Zack, R. M., Irema, K., Kazonda, P., Leyna, G. H., Liu, E., Spiegelman, D. L., Fawzi, W. W., Njelekela, M. A., Killewo, J., & Danaei, G. (2016) · Journal of Hypertension · doi:10.1097/hjh.0000000000001117 · Cited by 36
“High blood pressure (BP) is the leading risk factor for stroke [4] and levels have been increasing substantially in eastern SSA, mirroring the stroke epidemic.”
BackgroundSelf-citationRacial/Ethnic Differences in Cardiometabolic Risk in a Community Sample of Sexual Minority Women
Caceres, B. A., Veldhuis, C. B., & Hughes, T. L. (2019) · Health Equity · doi:10.1089/heq.2019.0024 · Cited by 28
Bhagavathula, A. S., Shah, S. M. A., & Aburawi, E. H. (2021) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph182312693 · Cited by 34
“In addition, the observational results indicated that each 10-mmHg increase in systolic blood pressure (SBP) was associated with a 45% higher risk of ischemic heart disease and stroke (65%) in those aged 55–64 years [4].”
BackgroundAn Updated Approach to Antiobesity Pharmacotherapy: Moving Beyond the 5% Weight Loss Goal
Enright, C., Thomas, E., & Saxon, D. R. (2023) · Journal of the Endocrine Society · doi:10.1210/jendso/bvac195 · Cited by 32
Metabolic Signatures Elucidate the Effect of Body Mass Index on Type 2 Diabetes
Dong, Q., Sidra, S., Gieger, C., Wang‐Sattler, R., Rathmann, W., Prehn, C. P., Adamski, J., Köenig, W., Peters, A., Grallert, H., et al. (2023) · Metabolites · doi:10.3390/metabo13020227 · Cited by 32
Brooks, S. J., Smith, C., & Stamoulis, C. (2023) · International Journal of Obesity · doi:10.1038/s41366-023-01303-7 · Cited by 30
Murakami, K., Asayama, K., Satoh, M., Inoue, R., Tsubota‐Utsugi, M., Hosaka, M., Matsuda, A., Nomura, K., Murakami, T., Kikuya, M., et al. (2016) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.35766 · Cited by 36
Lartey, S. T., Si, L., Otáhal, P., de Graaff, B., Boateng, G. O., Biritwum, R. B., Minicuci, N., Kowal, P. R., Magnussen, C. G., & Palmer, A. J. (2020) · Social Science & Medicine · doi:10.1016/j.socscimed.2020.112821 · Cited by 27
Health impact assessment of PM2.5 from a planned coal-fired power plant in Taiwan
Chio, C., Lo, W., Tsuang, B., Hu, C.-C., Ku, K.-C., Chen, Y.-J., Lin, H.-H., & Chan, C. (2019) · Journal of the Formosan Medical Association · doi:10.1016/j.jfma.2019.08.016 · Cited by 27
Bouchard, P., Al-Masrouri, S., Demyttenaere, S. V., Court, O., & Andalib, A. (2022) · Obesity Surgery · doi:10.1007/s11695-021-05849-1 · Cited by 28
“Obesity is linked to major cardiovascular risk factors including diabetes mellitus (DM), hypertension (HTN), and dyslipidemia [1, 2].”
BackgroundCohorts Consortium of Latin America and the Caribbean (CC-LAC) (2022) · The Lancet Regional Health - Americas · doi:10.1016/j.lana.2022.100258 · Cited by 36
Marklund, M., Tullu, F. T., Thout, S. R., Yu, J., Brady, T. M., Appel, L. J., Neal, B. C., Wu, J. H. Y., & Gupta, R. (2022) · Hypertension · doi:10.1161/hypertensionaha.122.19072 · Cited by 32
COLLINS, B., KYPRIDEMOS, C., PEARSON‐STUTTARD, J., HUANG, Y., BANDOSZ, P., WILDE, P., KERSH, R., CAPEWELL, S., MOZAFFARIAN, D., WHITSEL, L. P., et al. (2019) · The Milbank Quarterly · doi:10.1111/1468-0009.12402 · Cited by 26
Self-citationSeferidi, P., Laverty, A. A., Pearson‐Stuttard, J., Bandosz, P., Collins, B., Guzman-Castillo, M., Capewell, S., O’Flaherty, M., & Millett, C. J. (2019) · BMJ Open · doi:10.1136/bmjopen-2018-026966 · Cited by 26
“Employing age-specific relative risks allowed us to incorporate the declining effect of age on the relationships between risk factors and CVD, which has been previously described.(21) The authors assumed a linear relationship between risk and mortality of the outcomes, that is, associations with incident CVD and CVD m…”
MethodLi, C., Li, Y., Zhao, M., Zhang, C., Bovet, P., & Xi, B. (2023) · JMIR Public Health and Surveillance · doi:10.2196/45521 · Cited by 27
Global burden and drivers of hyperglycemia: Estimates and predictions from 1990 to 2050
Qiu, H., Fan, S., Zhou, K., He, Z., Browning, M. H. E. M., Knibbs, L. D., Zhao, T., Luo, Y., Liu, X., Hu, L.-X., et al. (2023) · The Innovation · doi:10.1016/j.xinn.2023.100450 · Cited by 35
“Second, GBD 2019 defined high FPG with the theoretical minimum risk exposure level.(39) Its cut-off value (4.”
BackgroundGlobal health impacts of ambient fine particulate pollution associated with climate variability
Yim, S. H. L., Li, Y., Huang, T., Lim, J. T., Lee, H. F., Chotirmall, S. H., Dong, G., Abisheganaden, J. A., Wedzicha, J. A., Schuster, S. C., et al. (2024) · Environment International · doi:10.1016/j.envint.2024.108587 · Cited by 33
Lifetime Trauma and Cardiometabolic Risk in Sexual Minority Women
Caceres, B. A., Veldhuis, C. B., Hickey, K. T., & Hughes, T. L. (2019) · Journal of Women s Health · doi:10.1089/jwh.2018.7381 · Cited by 30
“Obesity is a significant risk factor for CVD(63) that contributes to complex physiological mechanisms associated with increased prevalence of hypertension and type 2 diabetes.(70,71) Previous work has found that body mass index accounts for 50% and 60% of the association between childhood trauma and hypertension and d…”
BackgroundHao, Q., Song, X., Yang, M. J., Dong, B., & Rockwood, K. J. (2015) · The journal of nutrition health & aging · doi:10.1007/s12603-015-0553-5 · Cited by 25
New role of fat-free mass in cancer risk linked with genetic predisposition
Harris, B. H. L., Di Giovannantonio, M., Zhang, P., Harris, D. A., Lord, S. R., Allen, N. E., Maughan, T. S., Bryant, R. J., Harris, A. L., Bond, G. L., et al. (2024) · Scientific Reports · doi:10.1038/s41598-024-54291-7 · Cited by 24
Suara, S. B., Siassi, F., Saaka, M., Foroshani, A. R., Asadi, S., & Sotoudeh, G. (2020) · Lipids in Health and Disease · doi:10.1186/s12944-020-01227-5 · Cited by 31
“According to epidemiological studies, the disease burden of obesity is enormous, it increases the risk of infertility in women [4, 5], metabolic syndrome [6, 7], cardiovascular diseases, type 2 diabetes mellitus (T2DM), chronic kidney disease [8], multiple cancers [9] and musculoskeletal complications [10, 11].”
Sisa, I., Gilardon, E. O. A., Fisberg, R. M., Jackson, M. D., Mangialavori, G. L., Sichieri, R., Cudhea, F., Bannuru, R. R., Ruthazer, R., Mozaffarian, D., et al. (2020) · Public Health Nutrition · doi:10.1017/s1368980020000646 · Cited by 29
“those from randomised controlled trials(16,26).”
Self-citationLi, X., Han, F., Liu, N., Feng, X., Sun, X., Chi, Y., Hou, N., & Liu, Y. (2023) · BMJ Open · doi:10.1136/bmjopen-2023-075437 · Cited by 29
The association between heavy metal exposure and obesity: A systematic review and meta-analysis
Zangiabadian, M., Jolfayi, A. G., Nejadghaderi, S. A., Amirkhosravi, L., & Sanjari, M. (2023) · Journal of Diabetes & Metabolic Disorders · doi:10.1007/s40200-023-01307-0 · Cited by 28
“…significantly increases the risk of diseases such as hypertension, myocardial infarction [4], type 2 diabetes, fatty liver disease, stroke, dementia, osteoarthritis, obstructive sleep apnea [5, 6], and various cancers [7] all of which lead to a decline in both life expectancy and quality of life.”
Traditional Cardiovascular Risk Factors for Incident Atrial Fibrillation
Kokubo, Y., & Matsumoto, C. (2016) · Circulation Journal · doi:10.1253/circj.cj-16-0919 · Cited by 29
Nilson, E. A. F., Pearson‐Stuttard, J., Collins, B., Guzman-Castillo, M., Capewell, S., O’Flaherty, M., Jaime, P. C., & Kypridemos, C. (2021) · BMC Medicine · doi:10.1186/s12916-021-02099-x · Cited by 36
The Economic Impact of Obesity in Turkey: A Micro-Costing Analysis
Yavuz, D. G., Akhtar, O., Low, K., Gras, A., Gürser, B., Yılmaz, E. Ş., & Basse, A. (2024) · ClinicoEconomics and Outcomes Research · doi:10.2147/ceor.s446560 · Cited by 28
Lei, L., Li, J., Ding, W., Wang, W., Yu, Y., Pu, B., Peng, Y., Zhang, L., & Guo, Y. (2025) · Cardiorenal Medicine · doi:10.1159/000546618 · Cited by 29
Wang, Y. Y., Wang, Y., Qi, X.-Y., Liao, Z., Mai, Y.-N., & Xiao, X. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.839849 · Cited by 30
Song, Y., Zhu, J., Dong, Z., Wang, C., Xiao, J., & Yang, W. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1102017 · Cited by 26
Carlos, S., de Irala, J., Hanley, M., & Martínez‐González, M. Á. (2014) · Journal of Epidemiology & Community Health · doi:10.1136/jech-2014-203884 · Cited by 29
Tuck, N. L., Adams, K. S., Pressman, S. D., & Consedine, N. S. (2017) · Journal of Behavioral Medicine · doi:10.1007/s10865-017-9852-0 · Cited by 27
“Given that the biological, behavioral, and demographic risk factors measured here are relevant to other chronic conditions, notably diabetes (Singh et al., 2013; Wulsin et al., 2015), the observed links between skills and CVD risk scores may extend to other health outcomes.”
Lartey, S. T., de Graaff, B., Magnussen, C. G., Boateng, G. O., Aikins, M., Minicuci, N., Kowal, P. R., Si, L., & Palmer, A. J. (2019) · Health Policy and Planning · doi:10.1093/heapol/czz147 · Cited by 23
Hypertension therapy using fixed-dose polypills that contain at least three medications
O’Hagan, E. T., McIntyre, D., Nguyen, T. N., & Chow, C. K. (2023) · Heart · doi:10.1136/heartjnl-2022-321496 · Cited by 24
Lu, Y., Ezzati, M., Rimm, E. B., Hajifathalian, K., Ueda, P., & Danaei, G. (2016) · Circulation · doi:10.1161/circulationaha.115.018102 · Cited by 23
Self-citationCogswell, M. E., Patel, S., Yuan, K., Gillespie, C., Juan, W., Curtis, C. J., Vigneault, M., Clapp, J. E., Roach, P., Moshfegh, A. J., et al. (2017) · American Journal of Clinical Nutrition · doi:10.3945/ajcn.116.145623 · Cited by 22
Gaiţă, L., Timar, R. Z., Lupascu, N., Roman, D., Albai, A., Potre, O., & Timar, B. (2019) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s222570 · Cited by 24
“Its presence is strongly associated with an increase in the incidence of both stable and unstable angina, non-fatal myocardial infarction, heart failure and peripheral arterial disease,(2) doubling or even tripling the risk of developing atherosclerotic cardiovascular disease (ASCVD), the leading cause of mortality in…”
BackgroundNilson, E. A. F., da Silva, E. N., & Jaime, P. C. (2020) · Journal of Clinical Hypertension · doi:10.1111/jch.13836 · Cited by 23
Tripp, M. L., Dahlberg, C. J., Eliason, S., Lamb, J. J., Ou, J. J., Gao, W., Bhandari, J., Graham, D., Dudleenamjil, E., & Babish, J. G. (2019) · Journal of Medicinal Food · doi:10.1089/jmf.2018.0063 · Cited by 25
Memish, Z. A., Chang, J., Saeedi, M. Y., Hamid, M., Abid, O., & Ali, M. K. (2015) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2014.0267 · Cited by 24
Self-citationObesity and Natural Spaces in Adults and Older People: A Systematic Review
Teixeira, A. S., Gabriel, R., Quaresma, L. F. E. S., Alencoão, A., Martinho, J., & Moreira, H. (2021) · Journal of Physical Activity and Health · doi:10.1123/jpah.2020-0589 · Cited by 24
Jevtovic, F. (2021) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s328694 · Cited by 22
“glucose levels, even in the prediabetic state, where glucose levels are not sufficient for a diabetes diagnosis.(6) Einarson and colleagues(7) concluded that approximately 32.”
BackgroundLoss of TRIM67 Attenuates the Progress of Obesity-Induced Non-Alcoholic Fatty Liver Disease
Huang, C., Wei, X., Luo, Q., Xia, Y., Pan, T. S., He, J., Jahangir, A., Jia, L., Liu, W., Zou, Y., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23137475 · Cited by 24
Hare, M. J. L., Maple-Brown, L. J., Shaw, J. E., Boyle, J. A., Lawton, P. D., Barr, E. L. M., Guthridge, S., Webster, V., Hampton, D., Singh, G., et al. (2023) · Diabetologia · doi:10.1007/s00125-023-05868-w · Cited by 21
Self-citationDehghani, A., Korozhdehi, H., Khalilzadeh, S. H., Fallahzadeh, H., & Rahmanian, V. (2023) · Health Science Reports · doi:10.1002/hsr2.1170 · Cited by 25
“The risk of CVD increases with the fasting plasma glucose level even before reaching the diagnosis level of diabetes.(43) Diabetes causes irreversible damage to blood vessels, thus leading to the macrovascular (coronary artery disease, stroke) and microvascular (retinopathy, nephropathy, neuropathy) complications.”
BackgroundDisparities in high fasting plasma glucose-related cardiovascular disease burden in China
Cao, X., Tian, Y., Zhao, Z., Wang, L., Wang, X., Zheng, C., Hu, Z., Gu, R., Xue, Y., Pei, X., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-53236-y · Cited by 23
“…fi cally, we quanti fi ed the burden of death from CVD and its subtypes attributable to FPG, including ischaemic heart disease, ischaemic stroke, haemorrhagic stroke when there was suf fi cient evidence of an association according totheWorld Cancer Research Fund criteriaandthe GBD 2019study 6,41 .”
Haggag, A. Z., Xu, J., Butcher, L., Pagnussat, S., Davies, G., Lundqvist, S., Wang, W., van Zuydam, N. R., Nelander, K., Jha, A., et al. (2024) · Diabetes Obesity and Metabolism · doi:10.1111/dom.16047 · Cited by 22
Obesity as a risk factor for tooth loss over 5 years: A population‐based cohort study
Vallim, A. C., Gaio, E. J., Oppermann, R. V., Rõsing, C. K., Albandar, J. M., Susin, C., & Haas, A. N. (2020) · Journal Of Clinical Periodontology · doi:10.1111/jcpe.13378 · Cited by 24
Why and when to screen for cardiovascular disease in healthy individuals
Lindholt, J. S., & Søgaard, R. (2021) · Heart · doi:10.1136/heartjnl-2019-316266 · Cited by 20
LDL-C:HDL-C ratio and common carotid plaque in Xinjiang Uygur obese adults: a cross-sectional study
Zhao, Q., Liu, F., Wang, Y.-H., Lai, H., Zhao, Q., Luo, J., Ma, Y.-T., Li, X., & Yang, Y. (2018) · BMJ Open · doi:10.1136/bmjopen-2018-022757 · Cited by 20
“Epidemiological studies have identified obesity as a risk factor for an expanding set of chronic diseases, including CVD, DM, dyslipidaemia, hypertension and chronic kidney disease.(30) 31 Recent studies have reported that obesity increased the risk of subclinical carotid AS.”
Cardiovascular Disease among Patients with Diabetes: The Current Scenario in Saudi Arabia
Robert, A. A., & Dawish, M. A. A. (2020) · Current Diabetes Reviews · doi:10.2174/1573399816666200527135512 · Cited by 25
Li, Y., Yatsuya, H., Tanaka, S., Iso, H., Okayama, A., Tsuji, I., Sakata, K., Miyamoto, Y., Ueshima, H., Miura, K., et al. (2020) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.58958 · Cited by 22
Evolution of Myocardial Dysfunction in Asymptomatic Patients at Risk of Heart Failure
Halabi, A., Yang, H., Wright, L. M., Potter, E. L., Huynh, Q. L., Negishi, K., & Marwick, T. H. (2020) · JACC. Cardiovascular imaging · doi:10.1016/j.jcmg.2020.09.032 · Cited by 20
Kim, Y., Son, D., Kim, B. K., Kim, K. H., Kim, K. H., Seo, K. W., Jung, K., Park, S. J., & Kim, J. H. (2022) · Endocrinology and Metabolism · doi:10.3803/enm.2022.1481 · Cited by 28
“Obesity is associated with cardiovascular disease, diabetes mellitus (DM), several types of cancers, musculoskeletal disorders, and poor mental health [2-5].”
BackgroundRelative validity and reliability of a diet risk score (DRS) for clinical practice
Johnston, E. A., Petersen, K. S., Beasley, J. M., Krussig, T., Mitchell, D. C., Van Horn, L. V., Weiss, R., & Kris-Etherton, P. M. (2020) · BMJ Nutrition, Prevention & Health · doi:10.1136/bmjnph-2020-000134 · Cited by 19
Intensive blood pressure lowering: a practical review
Camafort, M., Redón, J., Pyun, W. B., & Coca, A. (2020) · Clinical Hypertension · doi:10.1186/s40885-020-00153-z · Cited by 20
“suggests that the minimum risk BP level for CVD could be a SBP of 110 mmHg to 115 mm Hg [5, 6].”
BackgroundAdair, T. (2023) · International Journal of Obesity · doi:10.1038/s41366-023-01263-y · Cited by 19
Association of Body Fat Distribution and Risk of Breast Cancer in Pre- and Postmenopausal Women
Cao, Y., Xia, B., Zhang, Z., Hu, D., Huang, X., Yuan, J., & Li, F. (2023) · Obesity Facts · doi:10.1159/000529834 · Cited by 21
Ivanova, T. I., Churnosova, M., Abramova, M. Y., Plotnikov, D., Ponomarenko, I., Reshetnikov, E., Aristova, I., Николаевна, С. И., & Churnosov, M. I. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24097799 · Cited by 21
“to an increased risk of coronary heart disease by 45% and ischemic/hemorrhagic stroke by 63–66% in individuals aged 55–64 years [3].”
BackgroundSalsinha, A. S., Socodato, R., Rodrigues, A. C., Vale-Silva, R. S., Relvas, J. B., Pintado, M., & Rodríguez-Alcalá, L. M. (2023) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2023.159331 · Cited by 28
Dong, X., Zhang, X., Wang, B., Hou, F., & Jiao, Y. (2024) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2024.103025 · Cited by 24
Luca, T., Pezzino, S., Puleo, S., & Castorina, S. (2024) · Journal of Translational Medicine · doi:10.1186/s12967-024-05547-3 · Cited by 20
“For all these complications, obesity curtails life expectancy and is associated with a reduction in quality of life and increased healthcare costs [14, 18].”
BackgroundThe Evolving Epidemiology of Atherosclerotic Cardiovascular Disease in People with Diabetes
Pasquel, F. J., Gregg, E. W., & Ali, M. K. (2018) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2017.11.001 · Cited by 21
Self-citationProm-in, S., Kaewsrichan, J., Wangpradit, N., Hui, C. K., Yahaya, M. F., Kamisah, Y., & Kumar, J. (2020) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph17155513 · Cited by 20
“Being obese or overweight increases the risk of developing various non-communicable diseases, such as Diabetes Mellitus [5], cardiovascular disease [6], cancer [7] and even dementia [8].”
BackgroundNakanishi, M., Mizuno, T., Mizokami, F., Koseki, T., Takahashi, K., Tsuboi, N., Katz, M., Lee, J. K., & Yamada, S. (2020) · Journal of Clinical Pharmacy and Therapeutics · doi:10.1111/jcpt.13262 · Cited by 19
Impact of protocatechuic acid on high fat diet-induced metabolic syndrome sequelae in rats
Nour, O. A., Ghoniem, H. A., Nader, M. A., & Suddek, G. M. (2021) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2021.174257 · Cited by 21
Effectiveness of Dietary Policies to Reduce Noncommunicable Diseases
Afshin, A., Micha, R., Webb, M., Capewell, S., Whitsel, L. P., Rubinstein, A. L., Prabhakaran, D., Suhrcke, M., & Mozaffarian, D. (2017) · World Bank, Washington, DC eBooks · doi:10.1596/978-1-4648-0518-9_ch6 · Cited by 20
Self-citationTrieu, K., Coyle, D. H., Rosewarne, E., Shahid, M., Yamamoto, R., Nishida, C., Neal, B. C., He, F. J., Marklund, M., & Wu, J. H. Y. (2023) · Hypertension · doi:10.1161/hypertensionaha.122.20105 · Cited by 22
Allott, E. H., Howard, L. E., Aronson, W. J., Terris, M. K., Kane, C. J., Amling, C. L., Cooperberg, M. R., & Freedland, S. J. (2016) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-15-0876 · Cited by 19
“Finally, given the established link between dyslipidemia and increased risk of death from causes other than prostate cancer (19), we repeated our main analyses using competing risks regression, treating nonprostate cancer death as a competing risk for biochemical recurrence.”
MethodInfluentialSubcutaneous adipose tissue: Implications in dermatological diseases and beyond
Ziadlou, R., Pandian, G. N., Hafner, J., Akdiş, C. A., Stingl, G., Maverakis, E., & Brüggen, M. (2024) · Allergy · doi:10.1111/all.16295 · Cited by 20
Guandalini, G. S., & Bangalore, S. (2018) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2018.02.020 · Cited by 19
Definition and introduction to epidemiology of obesity
Mehrzad, R. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-818839-2.00001-6 · Cited by 25
McKie, G. L., Shamshoum, H., Hunt, K. L., Thorpe, H. H. A., Dibe, H. A., Khokhar, J. Y., Doucette, C. A., & Wright, D. C. (2021) · The Journal of Physiology · doi:10.1113/jp281774 · Cited by 18
Metadata
- Authors
- Singh, G. M., Danaei, G., Farzadfar, F., Stevens, G. A., Woodward, M., Wormser, D., Kaptoge, S., Whitlock, G., Qiao, Q., Lewington, S., Di Angelantonio, E., vander Hoorn, S., Lawes, C. M. M., Ali, M. K., Mozaffarian, D., Ezzati, M., Global Burden of Metabolic Risk Factors of Chronic Diseases Collaborating Group; Asia-Pacific Cohort Studies Collaboration (APCSC), (DECODE), D. E. C. A. O. D. C. I. E., Emerging Risk Factor Collaboration (ERFC), & Prospective Studies Collaboration (PSC)
- Affiliations
- Harvard University (US)
- Tehran University of Medical Sciences (IR)
- World Health Organization (CH)
- The University of Sydney (AU)
- University of Cambridge (GB)
- University of Oxford (GB)
- University of Helsinki (FI)
- University of Auckland (NZ)
- Emory University (US)
- Brigham and Women's Hospital (US)
- MRC Centre for Environment and Health (GB)
- Corresponding author
- Ezzati, Majid
- ORCID
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2013-07-30
- Volume
- 8
- Issue
- 7
- Pages
- e65174
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC3728292
- OpenAlex
- W2122520859
- Cited by
- 772
- References
- 67
- Citations by year
- 2026: 29 · 2025: 64 · 2024: 84 · 2023: 87 · 2022: 103 · 2021: 86 · 2020: 85 · 2019: 66 · 2018: 43 · 2017: 49 · 2016: 41 · 2015: 18 · 2014: 16 · 2013: 1
- FWCI
- 19.82
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- PLoS ONE (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Research Publications (Maastricht University) (publishedVersion, cc-by)
- Pure Amsterdam UMC (publishedVersion)
- Research at the University of Copenhagen (University of Copenhagen) (publishedVersion)
- Amsterdam UMC (VU Amsterdam) - Institutional Repository (publishedVersion)
- University of Southern Denmark Research Portal (University of Southern Denmark) (publishedVersion)
- Monash University Research Portal (Monash University) (acceptedVersion, other-oa)
- LSHTM Research Online (London School of Hygiene and Tropical Medicine) (acceptedVersion)
- Digital Access to Scholarship at Harvard (DASH) (Harvard University) (submittedVersion, cc-by)
- RePEc: Research Papers in Economics (submittedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- UCL Discovery (University College London) (submittedVersion)
- Figshare (submittedVersion, cc-by)
- Työväentutkimus Vuosikirja (submittedVersion)
- Minerva Access (University of Melbourne) (submittedVersion, cc-by)
- Site cant be reached (submittedVersion, cc-by)
- University of Groningen research database (University of Groningen / Centre for Information Technology) (submittedVersion, cc-by)
- OPUS (Augsburg University) (submittedVersion, cc-by)
- Research Publications (Maastricht University) (submittedVersion, other-oa)
- Data Archiving and Networked Services (DANS) (submittedVersion, other-oa)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- Funders
- World Health Organization
- National Institute for Health and Care Research (NF-SI-0512-10165)
- British Heart Foundation (RG/08/013/25942, RG/07/008/23674, RG/08/014/24067)
- Imperial College London
- Imperial College Healthcare NHS Trust
- Medical Research Council (MR/K005901/1, MR/L003120/1)
- Economic and Social Research Council (ES/F02679X/1)
- National Institute of Diabetes and Digestive and Kidney Diseases (DK007703., T32DK007703)
- National Institute of Environmental Health Sciences (P30ES005605)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Health and Risk Factors
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Blood Pressure and Hypertension Studies
- Keywords
- metabolic risk factors, cardiovascular disease, diabetes mellitus, systolic blood pressure, total cholesterol, fasting blood glucose, body mass index, ischemic heart disease, hypertensive heart disease, stroke, sex differences, pooled cohort analysis, relative risk, effect modification by age
- MeSH terms
- Adult, Age Factors, Aged, Aged, 80 and over, Blood Glucose, Blood Pressure, Cardiovascular Diseases, Cholesterol, Diabetes Mellitus, Female, Humans, Male, Middle Aged, Risk, Sex Factors, Body Mass Index, Patient Outcome Assessment
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.